LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Understanding the variability of pharmaco‐epidemiological studies assessing the risk of appendicitis with mRNA COVID‐19 vaccines

Photo by matnapo from unsplash

Key Points • Results of cohort studies evaluating the risk of appendicitis after mRNA COVID-19 vaccines are heterogeneous. • Our analysis suggests that the discrepancies between results of these studies… Click to show full abstract

Key Points • Results of cohort studies evaluating the risk of appendicitis after mRNA COVID-19 vaccines are heterogeneous. • Our analysis suggests that the discrepancies between results of these studies is mainly linked to the choice of control groups. • Selection of comparator group was particularly difficult with COVID-19 vaccines given the large proportion of population exposed, often by using the same vaccine platform. • Using self-controlled design could be an interesting option to addresses these issues. • Sensitivity analyses are crucial to assess the degree of variability in the results of a study according to methodological choices.

Keywords: covid vaccines; covid; mrna covid; appendicitis mrna; risk appendicitis

Journal Title: Pharmacoepidemiology and Drug Safety
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.